Jung-Min Ahn , MD

Country Korea (Republic of)
Specialty Interventional Cardiologist
  1. FFR is a Routine Cath Lab Procedure
  2. FFR, It\'s Standard
  3. The Basics of Coronary Physiology Measurement: FFR, iFR and other NHPRs
  4. Updated Imaging/Physiology-Guided PCI Tuning 2021
  5. Under Pressure: Optimal Post-Dilation Strategy
  6. Difficult Wiring, Tips and Tricks
  7. TAVR for Bicuspid AS: Optimal Sizing & Valve Selection
  8. Imaging-guided PSP for Optimizing PCI
  9. How to Treat Tandem Lesion Under Physiology-Guidance
  10. Guide Extension Catheters: Strong Support from Mother-Child Relationship
  11. Post TAVR Coronary Access with Evolut System
  12. Self-Expandable Evolut R & PRO Valve
  13. TAVR for Bicuspid AV: Tips and Tricks
  14. Bifurcation PCI: Contemporary Practical Approach
  15. The Role of Debulking Atherectomy for Calcific In-stent Restenosis
  16. Prognosis of Discordant Lesion Between FFR and Hyperemia Free Indexes
  17. [Case-based Debate: Intracoronary Imaging Modalities for PCI Guidance] IVUS Is Better!
  18. Clinically Relevant PeriProcedural MI: Practical and Clinical Trial Aspect
  19. Case 1: Unexpanded ISR - Challenging and Optimal Treatment
  20. How Do I Implement?: FFR and Various Non-hyperemic Diastolic Index
  21. Current Status of Balloon-Expandable TAVR in Korea
  22. OAC in TAVR: FAILED GALILEO - NOAC Don\'t Work or Other Options?
  23. TAVR for Bicuspid AV: Tips and Tricks
  24. Synergetic Approach for Discordant Lesions Between FFR and Hyperemia Free Indexes
  25. Guide Extension Catheters: A Strong Support from a Parent-Child Relationship
  26. Expert Case Review: Complex PCI for Severe Calcified Coronary Disease
  27. Expert Case Review: Complex Bifurcation PCI
  28. Impact of Renal Function on Stroke or Systemic Embolism Following TAVR
  29. TAVR for Bicuspid Valve: Clinical Outcome and Technical Considerations
  30. TAVR: Bicuspid, Severe Calcium, and Low Lying Left Main
  31. TAVR in Bicuspid Aortic Stenosis with Severe Calcification: Case Reviews and Tips-and-Tricks
  32. How About Integrated Use of Resting Pd/Pa and FFR?
  33. Distal Left Main Bifurcation PCI: Concept Is More Important.
  34. [Case #2: Transcatheter Aortic Valve Implantation in a Patient with Type B Aortic Dissection] Part 2. How Would I Treat?
  35. FFR as the Gold Standard Index!
  36. Five-Year Outcomes of Routine FFR Use in Clinical Practice: Data from ASAN PCI Registry
  37. The Benefit of Complete Revascularization in Complex Coronary Artery Disease
  38. Asian Pacific TAVR Registry
  39. [Taped Case] TAVR with Evolut R
  40. Bicuspid AS: Future Perspectives of TAVR
  41. Integrated Use of FFR and IVUS for LM PCI
  42. Bicuspid TAVR Registry and TRANSIT Trial: TAVI Experience in AMC
  43. Bicuspid and Valve-in-Valve; How Different?
  44. Clinical Outcome of DEFER
  45. Left Main and MVD PCI: Imaging and Functional Guidance
  46. Utility of Intravascular Imaging for Resolving Issues During PCI
  47. Long Lesion and Tandem Lesion
  48. Bicuspid TAVR Registry
  49. AP TAVR Registry
  50. Current Status of TAVR: High/Intermediate and Lower Risk
  51. Clinical Impact of Routine FFR Measurement
  52. Tandem
  53. Prognostic Value of FFR: Insight from IRIS-FFR Registry
  54. Practical Aspect of IMR in AMI and Stable Angina
  55. Fate of FFR-Guided Deferral Data from IRIS-FFR Registry
  56. Elderly Population
  57. LM PCI 2016: Integrated Approach Using IVUS, FFR and New Imaging Modality
  58. [Review in 2015] Physiology
  59. Tandem Lesion Evaluation
  60. Integrated Use of IVUS and FFR in Real Practice
  61. Readmission After PCI or CABG
  62. Left Main
  63. Final Answer RESTORE
  64. Comparative Outcomes of Various DES from IRIS-MAIN Registry and PRECOMBAT Series
  65. Case Presentation 4: Medically Stabilized Type A Aortic Dissection After TAVI
  66. Randomzed Trial of Stents Versus Bypass Surgery for Left Main Coronary Artery Disease: Five-Year Outcomes of the PRECOMBAT Study
  67. Preliminary Data from IRIS FFR Registry
  68. Complex Lesions, Left Main, Bifurcations, Tandem, and More
  69. Left Main PCI
  70. Understanding About Visual-Functional Mismatching
  71. TAVI for Bicuspid Valve Stenosis
  72. FFR-guided PCI in Routine Practice: Learn from AMC Experiences
  73. Is There a Generation Gap of DES: Results of PRECOMBAT Study Series
  74. Comparison of Coronary Bypass Surgery with Drug-eluting Stenting for the Treatment of Left Main Disease: 3-year Follow-up of the PRECOMBAT Trial
  75. Clinical Implementation of FFR
  76. Case-based Review: Incidence and Treatment of LM ISR
  77. LM & Tandem Lesion
  78. VH IVUS: Native Plaque and Neointima
  79. Clinical Evidence of Neoatherosclerosis: ISR and Late Stent Thrombosis
  80. LM PCI
  81. IRIS-ELEMENT Data Review
  82. Cross and Perfect: 2013 Update
  83. Comparison of Platinum Chromium Versus Cobalt Chromium Everolimus-eluting Stent in Real World Practice: Outcomes from the Multicenter Prospective IRIS-DES Registry
  84. Anatomical - Functional Stenosis: How Much Discordant?
  85. Case Presentation: Functional Angioplasty
  86. Impact of Functional Angioplasty on Clinical Outcomes of PCI
  87. Novice's Trial of Complex LM PCI
  88. New-generation DES for Long Lesions: From a Large-scale Cohort Regis
  89. FFR Utilization in LM PCI
  90. Promus Element Clinical Program in Asan Medical Center
  91. FFR-guided PCI in Tandem Lesion
  92. Two Cases with Coronary Thromboembolism
  93. FFR Guided Functional Angioplasty
  94. Does the Timing of IABP Matter?